Federal officials have approved the start of human embryonic stem cell treatment experiments on patients suffering a leading cause of vision loss.

Read More

For only the second time, the Food and Drug Administration approved a company’s request to test an embryonic stem cell-based therapy on human patients.

Read More

The U.S. Food and Drug Administration has approved the second human trial of human embryonic stem cells — this one testing cells in people with a progressive form of blindness.

Read More

An American biotech company has just announced that it has been licensed to begin human trials of a stem cell treatment for blindness.

Read More

Government regulators have given the go-ahead to a second study that will for the first time carefully test a treatment created using human embryonic stem cells in people, according to the company sponsoring the experiment.

Read More

Federal officials have cleared a second clinical trial of a human embryonic stem-cell treatment, a company announced Monday, for a progressive blindness syndrome affecting young people.

Read More

NEW YORK (AP) – For only the second time, the U.S. government has approved a test in people of a treatment using embryonic stem cells – this time for a rare disease that causes serious vision loss.

Read More

Advanced Cell Technology, of Marlborough, Mass., said it would test its stem cell therapy on 12 adults with severe vision loss caused by Stargardt’s, an inherited disease. The company has turned human embryonic stem cells into retinal pigment epithelial cells, which will be surgically implanted into the eye. The hope is that the implanted cells […]

Read More